
Regulatory
- Research & Development (R & D)
- Clinical Research
- SAS (Statistical Analysis System)
- Dossiers
- Pharmacovigilance
our documentation






about us
Setting new standards in pharmaceutical documentation excellence,

We strive to deliver the best pharmaceutical documentation experience for you.

We are committed to delivering the highest standard of pharmaceutical documentation.
Pharmacist have main role in pharmaceuticals sector
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
sales associate

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
retail specialist

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
studio executive

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam lobortis laoreet ante, ut rutrum felis tincidunt vel. Proin tellus magna, malesuada sit amet justo non, interdum congue tortor. Donec volutpat sollicitudin urna consequat luctus.
Business Analyst

news & blogs
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin nisi elit, consequat pharetra elementum nec, eleifend non turpis.
Discover the most common regulatory inspection findings in pharmaceutical testing laboratories and learn GMP strategies to prevent FDA and WHO citations. Definition Regulatory inspection findings in pharmaceutical testing laboratories commonly involve inadequate Out-of-Specification (OOS) investigations, data integrity violations, equipment qualification failures, method validation deficiencies, and insufficient personnel training. Regulatory agencies such as the FDA, WHO,…
Compare GC-MS vs LC-MS for pharmaceutical impurity testing. Learn applications, regulatory requirements, advantages, limitations, and method selection. GC-MS and LC-MS are complementary analytical techniques used for pharmaceutical impurity testing. GC-MS is ideal for volatile and thermally stable impurities such as residual solvents, while LC-MS is preferred for polar, non-volatile, heat-sensitive, and high-molecular-weight impurities including degradation…
Learn how to perform dissolution method validation according to USP <1092>, including specificity, accuracy, precision, robustness, and GMP compliance. Definition Dissolution method validation according to USP <1092> is the documented process of demonstrating that a dissolution testing procedure consistently produces accurate, precise, specific, robust, and reliable results for measuring drug release from pharmaceutical dosage forms.…
Learn common analytical method transfer failures, regulatory expectations, validation requirements, and GMP best practices for pharmaceutical laboratories. Definition Analytical method transfer is a documented process that demonstrates a receiving laboratory can perform a validated analytical method and generate results equivalent to those obtained by the originating laboratory. Regulatory agencies expect method transfers to be scientifically…
Compare rapid microbiology methods and traditional microbial testing in pharmaceuticals. Learn advantages, validation, GMP requirements, and compliance. Definition Microbial contamination detection methods are analytical techniques used to identify, quantify, and monitor microorganisms in pharmaceutical products, manufacturing environments, and raw materials. Traditional methods rely on culture-based growth and colony counting, while rapid microbiological methods (RMMs) use…
Learn regulatory expectations, ICH M7 requirements, TTC limits, analytical methods, and GMP strategies for genotoxic impurity testing in pharmaceuticals. Definition Genotoxic impurity testing in pharmaceuticals involves identifying, assessing, controlling, and monitoring DNA-reactive impurities that may cause mutations or cancer. Regulatory expectations under ICH M7 require a risk-based approach using toxicological assessment, process controls, TTC limits,…
FAQ’s
Pharma Documentation Simplified.
Pharmaceutical documentation is the systematic recording of processes, procedures, tests, and controls involved in the manufacturing, quality assurance, and distribution of pharmaceutical products. It ensures product quality, safety, traceability, and regulatory compliance.
Documentation is critical to ensure:
• Compliance with regulatory requirements (GMP, DRAP, FDA, WHO, USP, BP)
• Product quality and patient safety
• Traceability and accountability
• Data integrity and audit readines
Common pharmaceutical documents include:
• Standard Operating Procedures (SOPs)
• Batch Manufacturing Records (BMR)
• Batch Packaging Records (BPR)
• Master Formula Records (MFR)
• Validation protocols and reports
• Quality control and stability reports
• Change control and deviation records
Good Documentation Practices (GDP) are guidelines that ensure documents are:
GDP helps maintain data integrity and regulatory compliance.
Accurate, clear, and legible
Written in real time
Properly signed and dated
Secure and traceable
All personnel involved in pharmaceutical operations share responsibility for accurate documentation. However, Quality Assurance (QA) is primarily responsible for document approval, control, revision, and archiving.
Common errors include:
* Incomplete or inconsistent records
* Missing signatures or dates
* Overwriting or use of correction fluid
* Backdating entries
* Illegible handwriting
Pharmaceutical documentation is governed by:
* USP, BP, and IP standards
* WHO-GMP guidelines
* FDA 21 CFR Parts 210, 211, and 11
* MHRA Act & Rules
* ICH guidelines
Documentation quality can be improved by:
* Regular staff training
* Standardized templates
* Routine audits and reviews
* Clear SOPs and GDP enforcement
* Use of digital documentation systems